Vaccine Design and Testing – News and Features

According to research, bird flu in unpasteurized milk is stable on metal and rubber components of commercial milking equipment for at least one hour, increasing its potential to infect people and other animals.

A new study, led by UC San Francisco, has found that COVID vaccine side effects symptoms indicate a robust immune response that is likely to lessen the chances of infection.

Researchers have uncovered important immune signatures in children with infected flares of eczema. Technology Networks spoke to Dr. Rachel McLoughlin to learn how these findings could guide the development of a tailored eczema vaccine.

A new study adds evidence supporting the safety of COVID-19 vaccination during pregnancy, finding that vaccination is not associated with an increased risk of preterm birth.

A scientific team has engineered a COVID-19 vaccine that induced – in pre-clinical models – very long-lasting, protective immunity against SARS-CoV-2 virus with a single-shot immunisation.

Using a combination of cutting-edge immunologic technologies, researchers have successfully stimulated animals’ immune systems to induce rare precursor B cells of a class of HIV broadly neutralizing antibodies (bNAbs).

Vaccination remains the most effective strategy for avian influenza prevention and control in humans, despite varying vaccine efficacy across strains.

Inhibiting a specific metabolic pathway in EBV-infected B cells can diminish infection and reduce the risk of downstream disease. A class of “failed” inhibitor drugs may now receive a second chance in applications aimed at dampening EBV infection.

An experimental mRNA vaccine against avian influenza virus H5N1 is highly effective in preventing severe illness and death in preclinical models.

A trial HIV vaccine has triggered low levels of HIV bnAbs in humans. The findings provide proof that a vaccine can elicit bnAbs to fight diverse strains of HIV and that it can initiate the process within weeks after just two immunizations.